dc.relation.reference | Adamson, A. L., and Kenney, S. (2001). Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75, 2388-2399.
Aragon, L. (2005). Sumoylation: A new wrestler in the DNA repair ring. Proc Natl Acad Sci U S A 102, 4661-4662.
Blank, V., and Andrews, N. C. (1997). The Maf transcription factors: regulators of differentiation. Trends Biochem Sci 22, 437-441.
Bohren, K. M., Nadkarni, V., Song, J. H., Gabbay, K. H., and Owerbach, D. (2004). A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 279, 27233-27238.
Cao, S., Liu, J., Chesi, M., Bergsagel, P. L., Ho, I. C., Donnelly, R. P., and Ma, X. (2002). Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J Immunol 169, 5715-5725.
Cohn, L., Elias, J. A., and Chupp, G. L. (2004). Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22, 789-815.
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., and Taylor, C. T. (2003). Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A 100, 986-991.
Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998). SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2, 233-239.
Dohmen, R. J. (2004). SUMO protein modification. Biochim Biophys Acta 1695, 113-131.
Estojak, J., Brent, R., and Golemis, E. A. (1995). Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol 15, 5820-5829.
Friedman, J. S., Khanna, H., Swain, P. K., Denicola, R., Cheng, H., Mitton, K. P., Weber, C. H., Hicks, D., and Swaroop, A. (2004). The minimal transactivation domain of the basic motif-leucine zipper transcription factor NRL interacts with TATA-binding protein. J Biol Chem 279, 47233-47241.
Fujiwara, K. T., Kataoka, K., and Nishizawa, M. (1993). Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene 8, 2371-2380.
Girdwood, D. W., Tatham, M. H., and Hay, R. T. (2004). SUMO and transcriptional regulation. Semin Cell Dev Biol 15, 201-210.
Guo, D., Li, M., Zhang, Y., Yang, P., Eckenrode, S., Hopkins, D., Zheng, W., Purohit, S., Podolsky, R. H., Muir, A., et al. (2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 36, 837-841.
Hilgarth, R. S., Murphy, L. A., Skaggs, H. S., Wilkerson, D. C., Xing, H., and Sarge, K. D. (2004). Regulation and function of SUMO modification. J Biol Chem 279, 53899-53902.
Ho, I. C., Hodge, M. R., Rooney, J. W., and Glimcher, L. H. (1996). The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
Ho, I. C., Lo, D., and Glimcher, L. H. (1998). c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med 188, 1859-1866.
Hwang, E. S., White, I. A., and Ho, I. C. (2002). An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines. Proc Natl Acad Sci U S A 99, 13026-13030.
Igarashi, K., Itoh, K., Motohashi, H., Hayashi, N., Matuzaki, Y., Nakauchi, H., Nishizawa, M., and Yamamoto, M. (1995). Activity and expression of murine small Maf family protein MafK. J Biol Chem 270, 7615-7624.
Johnson, E. S. (2004). Protein modification by SUMO. Annu Rev Biochem 73, 355-382.
Johnson, E. S., and Blobel, G. (1999). Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol 147, 981-994.
Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., and Yeh, E. T. (1998). Identification of three major sentrinization sites in PML. J Biol Chem 273, 26675-26682.
Kataoka, K., Fujiwara, K. T., Noda, M., and Nishizawa, M. (1994). MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol 14, 7581-7591.
Kataoka, K., Nishizawa, M., and Kawai, S. (1993). Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol 67, 2133-2141.
Kerppola, T. K., and Curran, T. (1994). A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 9, 3149-3158.
Kim, J. I., Ho, I. C., Grusby, M. J., and Glimcher, L. H. (1999). The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10, 745-751.
Lin, X., Liang, M., Liang, Y. Y., Brunicardi, F. C., Melchior, F., and Feng, X. H. (2003). Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem 278, 18714-18719.
Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107.
Matunis, M. J., Coutavas, E., and Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135, 1457-1470.
Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., and Yasuda, H. (2002). Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J Biol Chem 277, 50131-50136.
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348-2357.
Muller, S., Ledl, A., and Schmidt, D. (2004). SUMO: a regulator of gene expression and genome integrity. Oncogene 23, 1998-2008.
Muller, S., Matunis, M. J., and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J 17, 61-70.
Murphy, K. M., and Reiner, S. L. (2002). The lineage decisions of helper T cells. Nat Rev Immunol 2, 933-944.
Nishizawa, M., Kataoka, K., Goto, N., Fujiwara, K. T., and Kawai, S. (1989). v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A 86, 7711-7715.
Ogino, H., and Yasuda, K. (1998). Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science 280, 115-118.
Osada, H., Furukawa-Nakanishi, K., Miyamoto, D., Kobayashi, Y., and Osawa, T. (1989). Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor. Lymphokine Res 8, 393-405.
Rangasamy, D., Woytek, K., Khan, S. A., and Wilson, V. G. (2000). SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J Biol Chem 275, 37999-38004.
Rodriguez, M. S., Dargemont, C., and Hay, R. T. (2001). SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 276, 12654-12659.
Rui, H. L., Fan, E., Zhou, H. M., Xu, Z., Zhang, Y., and Lin, S. C. (2002). SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 277, 42981-42986.
Sherman, M. A., Nachman, T. Y., and Brown, M. A. (1999). Cutting edge: IL-4 production by mast cells does not require c-maf. J Immunol 163, 1733-1736.
Sobko, A., Ma, H., and Firtel, R. A. (2002). Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev Cell 2, 745-756.
Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G., and Chen, Y. (2004). Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A 101, 14373-14378.
Stelter, P., and Ulrich, H. D. (2003). Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425, 188-191.
Swain, S. L., Weinberg, A. D., English, M., and Huston, G. (1990). IL-4 directs the development of Th2-like helper effectors. J Immunol 145, 3796-3806.
Terui, Y., Saad, N., Jia, S., McKeon, F., and Yuan, J. (2004). Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J Biol Chem 279, 28257-28265. | en |